It wasn’t enough for Democratic Representatives Kurt Schrader of Oregon, Scott Peters of California, Kathleen Rice of New York and Stephanie Murphy of Florida to vote against a robust bill that would allow Medicare to negotiate drug prices, the Lower Drug Costs Now Act (H.R. 3). These politicians — compelled by their unhappy corporate donors — tried to derail efforts to lower the cost of prescription drugs by introducing a toothless alternative in a pathetic public stunt to appease the industry.

The post Corporate Democrats’ Toothless Drug Pricing Alternative Is A Coup For Big Pharma appeared first on PopularResistance.Org.

This post was originally published on PopularResistance.Org.